X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs AJANTA PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD AJANTA PHARMA WYETH LTD/
AJANTA PHARMA
 
P/E (TTM) x 27.7 20.7 133.7% View Chart
P/BV x 5.3 4.8 112.4% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   AJANTA PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
AJANTA PHARMA
Mar-18
WYETH LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,818 57.4%   
Low Rs8181,106 74.0%   
Sales per share (Unadj.) Rs298.6239.5 124.7%  
Earnings per share (Unadj.) Rs57.252.8 108.4%  
Cash flow per share (Unadj.) Rs58.459.5 98.2%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.5230.0 108.5%  
Shares outstanding (eoy) m22.7288.77 25.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.16.1 51.1%   
Avg P/E ratio x16.327.7 58.7%  
P/CF ratio (eoy) x15.924.6 64.9%  
Price / Book Value ratio x3.76.4 58.7%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,157129,782 16.3%   
No. of employees `0000.56.8 7.2%   
Total wages/salary Rs m4003,765 10.6%   
Avg. sales/employee Rs Th13,787.43,128.4 440.7%   
Avg. wages/employee Rs Th813.0554.0 146.7%   
Avg. net profit/employee Rs Th2,643.3689.7 383.3%   
INCOME DATA
Net Sales Rs m6,78321,258 31.9%  
Other income Rs m353242 145.9%   
Total revenues Rs m7,13621,499 33.2%   
Gross profit Rs m1,6176,584 24.6%  
Depreciation Rs m27596 4.5%   
Interest Rs m64 134.1%   
Profit before tax Rs m1,9386,226 31.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,539 41.1%   
Profit after tax Rs m1,3014,686 27.8%  
Gross profit margin %23.831.0 77.0%  
Effective tax rate %32.624.7 132.0%   
Net profit margin %19.222.0 87.0%  
BALANCE SHEET DATA
Current assets Rs m6,98412,236 57.1%   
Current liabilities Rs m2,0563,461 59.4%   
Net working cap to sales %72.641.3 176.0%  
Current ratio x3.43.5 96.1%  
Inventory Days Days9960 164.9%  
Debtors Days Days2484 28.3%  
Net fixed assets Rs m24411,140 2.2%   
Share capital Rs m227177 128.4%   
"Free" reserves Rs m5,44120,237 26.9%   
Net worth Rs m5,66820,414 27.8%   
Long term debt Rs m2510 247.5%   
Total assets Rs m7,90124,486 32.3%  
Interest coverage x353.31,519.4 23.3%   
Debt to equity ratio x00 891.5%  
Sales to assets ratio x0.90.9 98.9%   
Return on assets %16.519.2 86.3%  
Return on equity %22.923.0 99.9%  
Return on capital %34.030.5 111.6%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1511,667 0.1%   
Fx outflow Rs m2,6771,616 165.7%   
Net fx Rs m-2,66210,052 -26.5%   
CASH FLOW
From Operations Rs m9232,854 32.3%  
From Investments Rs m317-2,604 -12.2%  
From Financial Activity Rs m-481-2 24,050.0%  
Net Cashflow Rs m759248 306.0%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 1.6 729.0%  
FIIs % 7.2 7.6 94.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 17.0 178.8%  
Shareholders   21,978 20,968 104.8%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   GSK PHARMA  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Trade War Fears; Widening of Trade Deficit and Top Stocks in Action Today(Pre-Open)

Indian share markets trimmed their day's losses and ended flat on Friday amid weakness in their Asian peers, that wobbled on Friday as investors braced for US tariffs against China.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - UNICHEM LAB COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS